Abstract:Abstract Introduction Vagus nerve stimulation (VNS) is an effective therapy for epilepsy that has previously been suggested to worsen obstructive and central sleep apnea. Management of medically complex patients in the traditional sleep laboratory can present logistical barriers given the minimal medical oversight. Innovative forms of sleep monitoring offer new options to evaluate sleep serially. Report of case(s) A 69-year-old female with a history of medically refractory generalized epilepsy, on a vagal nerve stimulator, presented to sleep clinic in September of 2022 after undergoing a polysomnogram significant for severe sleep apnea with AHI 3% of 56, AHI 4% of 48, and oxygen nadir of 83%. A November 2022 titration was unsuccessful (residual AHI of 48 and oxygen desaturation nadir of 88%). Periodic breathing proved refractory to CPAP, BiPAP, BiPAP S/T, adaptive servo-ventilation, and attempts to mitigate high loop gain physiology with CO2 modulation techniques, acetazolamide, and supplemental oxygen. VNS setting could not be manipulated in the sleep laboratory safely. She was placed on CPAP setting of 5-10 cm H2O with compliance data showing average residual AHI of 24.3 and 29% of nights being in Hunter-Cheyne-Stokes breathing (HCSB). A planned hospital admission in July 2023 was arranged to monitor sleep with the SleepImage Ring system, which offered measurement of AHI and periodicity without the need for manual scoring. The VNS battery proved depleted during the stay but 5 nights on the same CPAP settings with the VNS off showed a residual AHI 4% of 1-3 with minimal periodic breathing. Patient underwent replacement of VNS generator with reduction of output current to 1/3 of prior value with gradual up-titration. Subsequent CPAP compliance data showed gradual increase in AHI and periodic breathing with rising VNS setting. Currently, the patient is undergoing VNS adjustments to optimize seizure control with plans to restudy sleep breathing at lower nocturnal settings when stabilized. Conclusion Sleep apnea induced by VNS can be refractory to therapy. Tracking sleep with the SleepImage system and PAP compliance data allowed understanding of the role of neurostimulation in inducing sleep dysfunction. Support (if any) Institute for Personalized Sleep Health, Beth Israel Deaconess Medical Center

What problem does this paper attempt to address?

### Problems the paper attempts to solve This paper mainly discusses refractory central sleep apnea (CSA) caused by vagus nerve stimulation (VNS). Specifically, through a case report, the paper explores the following issues: 1. **The impact of VNS on sleep**: VNS is an effective therapy for treating epilepsy, but previous studies have shown that it may exacerbate obstructive and central sleep apnea. Therefore, the paper attempts to understand the specific impact of VNS in specific patients. 2. **Management of refractory sleep apnea**: In this case report, the patient has tried multiple treatment methods (such as CPAP, BiPAP, adaptive servo - ventilation, etc.), but with poor results. The paper explores how to manage and optimize the treatment plans for these patients. 3. **Application of new sleep monitoring techniques**: Traditional sleep laboratories may not be able to provide sufficient medical supervision, especially when dealing with complex patients. The paper introduces a new method of sleep monitoring using the SleepImage Ring system, which can measure AHI and periodic breathing without manual scoring. ### Overview of the case report - **Patient background**: A 69 - year - old woman with drug - refractory generalized epilepsy and using a vagus nerve stimulator. She underwent a polysomnography in September 2022, and the results showed severe sleep apnea (AHI 3% was 56, AHI 4% was 48, and the lowest oxygen saturation was 83%). - **Treatment attempts**: The titration test in November 2022 failed (residual AHI was 48, and the lowest oxygen saturation was 88%). Periodic breathing was ineffective against CPAP, BiPAP, BiPAP S/T, adaptive servo - ventilation, and attempts to reduce high - loop - gain physiology through CO2 regulation techniques, acetazolamide, and supplemental oxygen. For safety reasons, it was not possible to adjust VNS settings in the sleep laboratory. - **Subsequent monitoring**: In July 2023, during the patient's hospitalization, sleep was monitored using the SleepImage Ring system. It was found that after the VNS battery was depleted, with the same CPAP settings (5 - 10 cm H2O), the residual AHI 4% was 1 - 3, and periodic breathing was significantly reduced. After replacing the VNS generator and gradually increasing the output current, CPAP compliance data showed a gradual increase in AHI and periodic breathing. - **Current situation**: The patient is undergoing VNS adjustment to optimize epilepsy control and plans to re - evaluate sleep breathing at low settings at night after stabilization. ### Conclusions - **Main conclusion**: Sleep apnea caused by VNS may be resistant to treatment. Using the SleepImage system and PAP compliance data is helpful for understanding the role of nerve stimulation in inducing sleep dysfunction. ### Support - **Supporting institution**: Institute for Personalized Sleep Health at Beth Israel Deaconess Medical Center. This paper, through detailed case reports and the application of new monitoring techniques, provides an important reference for understanding and managing refractory sleep apnea caused by VNS.

1213 Vagal-nerve Stimulation Induced Refractory Central Sleep Apnea

1225 Vagal Nerve Stimulator-induced Sleep Disordered Breathing

1163 Central Sleep Apnea: A Possible Rare Adverse Effect of Vagus Nerve Stimulation

1019 New onset OSA after long term Vagus Nerve Stimulator implantation in a patient with Lennox-Gastaut syndrome: A case report

1168 Snoring Cessation in a Case of Vagal Nerve Stimulator Induced Obstructive Hypopnea

1004 A novel use of adaptive servo ventilation for VNS-induced central sleep apnea in an adolescent with refractory epilepsy

1155 Exploring Vagus Nerve Stimulation (VNS) and Its Relationship with Sleep Apnea: Implications and Insights

Refractory Obstructive Sleep Apnea Secondary to Vagal Nerve Stimulation

Depicting and defining sleep disturbed breathing associated with vagal nerve stimulation

Bi-level VNS therapy with different therapy modes at night and daytime improves seizures and quality of life in a patient with drug-resistant epilepsy

1173 Unmasking Severe OSA After Transvenous Phrenic Nerve Stimulation for Central Sleep Apnea

1229 Dual Neurostimulator Therapy for CSA and OSA in an Elderly Gentleman with Native Pacemaker

0618 Phrenic Nerve Stimulation for Central Sleep Apnea: A Single Institution Experience

Vagal nerve stimulator-associated sleep disordered breathing secondary to vagal-induced laryngospasm in pediatric populations: Case presentation and systematic review

Efficacy and Potential Predictors of Vagus Nerve Stimulation Therapy in Refractory Postencephalitic Epilepsy.

Vagus nerve stimulation for the treatment of narcolepsy

Long-Term Seizure Outcome With or Without Vagal Nerve Stimulation Therapy

Vagus Nerve Stimulation Therapy For The Treatment Of Seizures In Refractory Postencephalitic Epilepsy: A Retrospective Study

Efficacy and safety of VNS therapy or continued medication management for treatment of adults with drug-resistant epilepsy: systematic review and meta-analysis

1188 Decreased Tolerance to Hypoglossal Nerve Stimulator After Cardioversion

0459 Cardiovascular Endpoints for Obstructive Sleep Apnea with Twelfth Nerve Stimulation: Measures of Sleep-Related Function